Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20003375HPVENSG00000204681.11protein_codingGABBR1NoNo2550Q5SUJ9
Q8IW08
Q9UBS5
TVIS20006860HPVENSG00000204681.11protein_codingGABBR1NoNo2550Q5SUJ9
Q8IW08
Q9UBS5
TVIS44022560HTLV-1ENSG00000204681.11protein_codingGABBR1NoNo2550Q5SUJ9
Q8IW08
Q9UBS5
TVIS44022561HTLV-1ENSG00000204681.11protein_codingGABBR1NoNo2550Q5SUJ9
Q8IW08
Q9UBS5
TVIS44050516HTLV-1ENSG00000204681.11protein_codingGABBR1NoNo2550Q5SUJ9
Q8IW08
Q9UBS5
TCGA Plot Options
Drug Information
GeneGABBR1
DrugBank IDDB00659
Drug NameAcamprosate
Target IDBE0000217
UniProt IDQ9UBS5
Regulation Typeinhibitor
PubMed IDs23278595; 9514305
CitationsKalk NJ, Lingford-Hughes AR: The clinical pharmacology of acamprosate. Br J Clin Pharmacol. 2014 Feb;77(2):315-23. doi: 10.1111/bcp.12070.@@Berton F, Francesconi WG, Madamba SG, Zieglgansberger W, Siggins GR: Acamprosate enhances N-methyl-D-apartate receptor-mediated neurotransmission but inhibits presynaptic GABA(B) receptors in nucleus accumbens neurons. Alcohol Clin Exp Res. 1998 Feb;22(1):183-91.
GroupsApproved; Investigational
Direct ClassificationOrganosulfonic acids
SMILESCC(=O)NCCCS(O)(=O)=O
Pathways
PharmGKBPA10344
ChEMBLCHEMBL1201293